Aspirin Prices

Aspirin Prices September 2024

The aspirin prices in the United States for Q3 2024 reached 3300 USD/MT in September. The price of aspirin had a notable increase in the North America region in Q3 2024, with the United States showing significant noticeable shifts. This market dynamic was impacted by a wide range of factors, such as strong product adoption brought on by fiscal buoyancy, interruptions in the distribution network such as port traffic and transportation setbacks, and strategic inventory control techniques used by key players.

The price trend for aspirin in China for Q3 2024 settled at 2890 USD/MT in September. These general patterns were mirrored in the Chinese market, which saw the biggest price fluctuations. The market conditions in China, the biggest participant in the area, had a significant impact on Asia Pacific pricing. There was a discernible rise from the prior quarter, along with seasonal swings and a clear interrelation in cost movements. The market's dynamic nature was highlighted by the significant cost differences between the initial and latter half of the quarter.

In Germany, the aspirin prices for Q3 2024 reached 3190 USD/MT in September. Significant price hikes have occurred in the market, especially in this country, where price swings were most pronounced. Despite distribution chain problems brought on by international shipping issues, such as the Red Sea crisis, aspirin demand remained strong due to management of inventory beforehand by enterprises and increased consumer sentiment. In addition, the European Central Bank's interest rate changes and the region's slowing inflation have indirectly fueled price increases.

Aspirin Prices June 2024

The aspirin prices in the United States for Q2 2024 reached 2840 USD/MT in June. The region saw an increase in user demand as confidence in the pharmaceutical sector grew. Companies quickly moved to expand inventories, anticipating seasonal demand peaks and potential supply chain disruptions. This rising demand and ongoing logistical challenges underscored the steady price growth throughout the quarter.

The price trend for aspirin in China for Q2 2024 reached 2490 USD/MT in June. The market demonstrated stability despite an increase in user demand due to market confidence and advantageous export conditions. The currency devaluation enhanced the appeal of exports, increasing overseas orders. Although manufacturers responded with production hikes, supply constraints from limited inventories and cost pressures restricted availability, keeping the market steady but under strain.

In Germany, the aspirin prices for Q2 2024 reached 2725 USD/MT in June. The market faced a notable increase because of a recovery in economic activity and heightened demand. Local manufacturers faced supply challenges as user interest increased because of seasonal needs and business confidence. Geopolitical and logistical issues impacted supply chains, further tightening the market. Higher raw material costs amplified these pressures, driving a steady upward trend in pricing.

Aspirin Prices March 2024

In March 2024, aspirin prices in the United States were recorded at 2715 USD/MT, reflecting a series of complex factors impacting the market beyond typical influences. The pricing landscape was shaped significantly by the domestic market conditions, where fluctuations were driven by economic concerns, inflationary pressures, and seasonal trends.

Aspirin prices in China were documented at 2450 USD/MT in March, influenced by a noticeable drop in demand due to decreased orders from pharmaceutical and healthcare sectors. The Spring Festival closure and a contracting production output underscored an oversupply situation. The economic downturn globally further strained demand for exports from China, contributing to cautious management of inventories and cautious spending behavior.

In Germany, the price of aspirin settled at 2600 USD/MT in Q1 2024. The market witnessed a drop in prices, influenced by weak buyer sentiment and diminished regional orders. The anticipation of demand spikes related to cultural festivities led to increased stock levels, exacerbating the oversupply and further depressing prices. Economic decisions, such as unchanged interest rates and reduced freight costs, also played a role in shaping the market landscape.

Aspirin Prices December 2023

The aspirin prices in the United States for Q4 2023 reached 2830 USD/MT in December. The market saw a notable drop in prices in early October, influenced by sluggish regional demand and high inventory levels among traders. However, a resurgence in purchasing activity and improved consumer confidence later led to a temporary increase in prices, though this was followed by another drop in December due to excess supply and weakening demand from end use industries.

The price trend for aspirin in China for Q4 2023 settled at 2610 USD/MT in December. The market benefited from a recovery in production output and a seasonal increase in demand due to colder weather, which typically heightens the incidence of colds and flu. These factors combined to drive a noticeable increase in aspirin prices in November, reflecting a strong end to the quarter.

In Germany, the aspirin prices for Q4 2023 reached 2930 USD/MT in December. The prices were significantly influenced by the broader market dynamics in the region, including increased energy costs and tight supplies. However, a major reduction in inflation improved buying conditions, which, along with heightened demand due to seasonal cases in December, led to an overall increase in aspirin prices by the quarter's end.

Regional Coverage

The report provides a detailed analysis of the aspirin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the aspirin price trend.

Global Aspirin Price

The report offers a holistic view of the global aspirin pricing trends in the form of aspirin price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights the current price but also provides insights into aspirin historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into aspirin price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed aspirin demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Aspirin Price

Q3 2024:

A number of important variables have contributed to the notable upward trend in the aspirin pricing dynamics in Europe during Q3 2024. Substantial price hikes have occurred in the market, especially in Germany, where price swings were most pronounced. Despite the distribution chain problems brought on by international shipping issues, such as the Red Sea crisis, aspirin demand remained strong due to preemptive stock handling by enterprises and increased consumer sentiment. Furthermore, the European Central Bank's interest rate changes and the region's slowing inflation have implicitly fueled price increases.

Q2 2024:

In the second quarter of 2024, European aspirin prices continued to rise steadily because of increased demand and limited supply. Strong user activity, coupled with economic recovery, drove businesses to replenish previously reduced inventories, fueling additional demand pressures across the region. Widespread logistical problems, ranging from overcrowding in ports in Asia and Northern Europe to ongoing geopolitical disruptions, intensified supply issues and raised shipping costs. In Germany, aspirin prices reflected notable changes as robust economic growth enhanced business trust, resulting in a strong demand increase.

Q1 2024:

In Europe, the aspirin market in Q1 2024 was influenced by various factors leading to a general decrease in prices. This trend was supported by lower consumer confidence and reduced order volumes, specifically in regional markets, which created an oversupply. Companies ramped up their inventory levels in expectation of improved demand due to cultural events like the Chinese Lunar Year, which, in turn, contributed to further price drops. Economic policies, such as steady interest rates, also influenced consumer buying power, continuing the trend of weak demand. Additionally, reductions in freight rates during the quarter, as the shipping industry navigated geopolitical tensions, helped decrease overall logistical costs, further driving down prices within the pharmaceutical sector.

Q4 2023:

Throughout Europe, the market faced several challenges in the last quarter of 2023, including stock shortages and high energy costs, which pushed prices upwards. Increased consumer demand also played a crucial role in driving prices higher. In Germany, the market dynamics were similar, with added pressure from decreasing inflation that slightly improved consumer spending power. Seasonal increases in illnesses amid the festive month of December further spurred demand, contributing to the rising trend in aspirin prices across the continent.

This analysis can be extended to include detailed aspirin price information for a comprehensive list of countries.

North America Aspirin Price

Q3 2024:

Throughout the last quarter of 2024, the North American market experienced fluctuations. Prices surged initially due to higher costs of ammonia, a crucial raw material, impacting manufacturing expenses. The domestic aspirin demand was strong, specifically with the approach of the winter planting season, pushing prices up. Yet, challenges such as reduced availability in the local market and intensified global demand, especially from Indian markets due to reduced Chinese fertilizer exports, also influenced the market. Despite this, prices dropped later in the quarter due to an excess supply and decreased demand, exacerbated by logistical issues at the Panama Canal and alternative routing via the Suez Canal to avoid potential threats.

Q2 2024:

In the second quarter of 2024, the aspirin market in North America saw an upward shift in prices due to rising demand and logistical issues. Increased user confidence resulted in a rise in pharmaceutical usage, encouraging retailers to increase their stocks ahead of the busy season. Shipping delays pushed transportation costs higher, with fuel expenses adding to the financial strain. Geopolitical tensions contributed to this price rise, prompting companies to further stockpile inventory as a protective measure against potential supply interruptions. The United States recorded the sharpest price hikes, with seasonal demand amplifying the pressure. These combined factors created a favorable environment, shaping a trend of ongoing cost increases throughout Q2.

Q1 2024:

The first quarter of 2024 saw the aspirin market in North America responding to a complex set of variables that extended farther than the usual market drivers. The market conditions were largely shaped by the United States, where economic fluctuations played a significant role in the pricing trends observed. Initial price reductions were influenced by economic concerns leading to cautious consumer purchasing behavior. The market also reflected actions by pharma companies who were managing their inventories in anticipation of the New Year, affecting the supply chain. Mid-quarter, there were revivals in pricing due to logistical disturbances and limited storage capacities, but the quarter's end saw another dip in prices due to a combination of accumulated inventory and cost-reduction strategies by manufacturers.

Q4 2023:

The market in North America experienced fluctuations throughout the final quarter of 2023, characterized by shifting prices and varying demand levels. Early in the quarter, prices dropped due to high interest rates and active trading, but these conditions soon gave way to a brief period of price recovery in November, influenced by seasonal trends. However, December saw another dip in prices, due to an excess of supplies and reduced demand from key industries. The diverse economic activities, including trade measures and interest rate adjustments, had a significant influence on these market dynamics.

Specific aspirin historical data within the United States and Canada can also be provided.

Middle East and Africa Aspirin Price

The report explores the aspirin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on aspirin prices for countries can also be provided.

Asia Pacific Aspirin Price

Q3 2024:

The aspirin market in the Asia-Pacific area showed a clear upward trend during the third quarter of 2024. A number of important causes played a role in this change. Strong national and overseas demand was a major factor, as producers found it difficult to fulfill the spike in demand. In addition, rising input costs, geopolitical unpredictability, and logistical difficulties all contributed to price increases. These general patterns were mirrored in the Chinese market, which saw the biggest price fluctuations. The market conditions in China, the biggest participant in the area, had a significant impact on Asia Pacific pricing. There was a discernible rise from the prior quarter, along with seasonal swings and a clear association in price movements.

Q2 2024:

The aspirin market in the Asia Pacific region maintained steady pricing throughout Q2 2024 because of balanced production and consistent needs in local and global markets. Primary elements that added to this steadiness consisted of reliable production output, stable feedstock price, and manageable increases in transportation costs. China experienced a dynamic market activity, with demand rise tied to greater use confidence and favorable export conditions due to currency shifts. The Middle East's eased geopolitical tensions also encouraged more shipments, creating steady trading conditions. However, manufacturers struggled with tight commodities and rising manufacturing expenses, which limited their capability to meet the fast-growing demand. This steady market situation, reflected by only minimal pricing shifts, emphasizes the resilience of the region's market amid varying global conditions.

Q1 2024:

Throughout Q1 2024, the Asia Pacific region, especially China, experienced notable shifts in the aspirin market. The period was marked by a price drop, primarily supported by a decrease in demand from critical sectors such as pharmaceuticals and healthcare. The annual Spring Festival led to temporary business closures, contributing to reduced market activity and high product inventories. Economic challenges continued to impact the region with faint demand in China’s industrial sector, exacerbated by an economic slowdown worldwide which affected exports. This surplus in aspirin was further fueled by strategic management of inventory and broader supply chain disruptions, leading to conservative buying behaviors and subdued consumer spending. This set of circumstances resulted in a downward pricing trend compared to the previous year.

Q4 2023:

During the Q4 2023, the market in the Asia Pacific region saw positive developments, with increased production and heightened market optimism. Notably, the aspirin demand surged, fueled by an upward trend in regional inquiries and higher needs in the healthcare sector, which typically sees a spike during the colder months. Additionally, the cost of key feedstocks such as salicylic acid rose, pushing aspirin prices upward. This was further driven by robust production output and an uptick in market demand, particularly in China, where the winter season boosted the demand for cold and flu remedies.

This aspirin price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Aspirin Price

The analysis of aspirin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Aspirin Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Aspirin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2024 Edition,” offers an in-depth analysis of aspirin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of aspirin at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of aspirin price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing aspirin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Aspirin Market Analysis

The global aspirin market size reached US$ 2.4 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 3.3 Billion, at a projected CAGR of 3.70% during 2023-2032.

• The aspirin market is shifting toward increased usage in preventative healthcare due to its potential benefits in reducing the risk of cardiovascular events and certain types of cancer, driven by growing emphasis on proactive health management. Aspirin's utility extends beyond pain relief to encompass diverse therapeutic areas such as cardiovascular health, stroke prevention, and cancer risk reduction, highlighting its versatility in addressing various health conditions. As per a report published by Centres for Disease Control and Prevention, every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. This in turn escalates the demand for aspirin.
• With an aging global population, there is a growing demand for medications like aspirin that address age-related health concerns such as cardiovascular disease and arthritis, reflecting the demographic shift towards older age groups. As per the report published by The Urban Institute, by 2040, about one in five Americans will be age 65 or older, up from about one in eight in 2000. The number of Americans ages 65 and older is projected to more than double over the next 40 years, reaching 80 million in 2040.
• Increasing healthcare access and rising disposable incomes in emerging markets are fueling demand for aspirin, particularly for preventative purposes, indicating its expanding market reach.
• Ongoing research and technological advancements in drug delivery systems are enhancing the efficacy and safety profile of aspirin formulations, driving innovation in the pharmaceutical industry.
• The advent of personalized medicine is leading to tailored aspirin therapies based on individual patient characteristics and genetic profiles, marking a shift towards precision healthcare approaches.
• Evolving regulatory frameworks and guidelines are shaping the development and marketing of aspirin-based products, influencing market dynamics and compliance standards.
• Intense competition among pharmaceutical companies is driving innovation in aspirin formulations and marketing strategies to capture market share, fostering a competitive landscape.

Aspirin News

The report covers the latest developments, updates, and trends impacting the global aspirin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in aspirin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the aspirin price trend.

Latest developments in the aspirin industry:

• July 2, 2024: A world-first study by RMIT University has found low-dose aspirin may treat flu-induced blood vessel inflammation, creating better blood flow to the placenta during pregnancy. Lead researcher and RMIT Post-Doctoral Research Fellow, Dr Stella Liong, said flu infections during pregnancy can resemble preeclampsia, a pregnancy complication that causes inflammation to the aorta and blood vessels. Low-dose aspirin is commonly taken to prevent preeclampsia, as it stops the body from creating chemicals that cause inflammation.

Product Description

Aspirin, also known as acetylsalicylic acid, is a broadly used medicine that offers relief from pain, reduction in inflammation and fever. It is esterified by the condensation of acetyl chloride with salicylic acid. Aspirin's mechanism of action derives from its ability to block enzyme cyclooxygenase which subsequently inhibits the formation of prostaglandins, the culprit of pain, inflammation and fevers.

Aspirin, as a medication, is usually produced by the chemical series reactions in the pharmaceutical manufacturing factories. The process involves the use of precise reaction conditions, purification procedures, and manufacturing techniques such as tablets, capsules, and parenteral solutions.

Aspirin is well-known for relief of mild to moderate pain including headaches, muscle aches, toothaches, and diarrhea. Moreover, it is found to be anti-inflammatory agent for the ease of symptoms of diseases like arthritis. Aspirin is no longer only used for the purpose of pain relief, but also in preventing cardiovascular events, such as heart attacks and strokes, by virtue of its inhibition of platelet aggregation.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of aspirin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting aspirin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The aspirin price charts ensure our clients remain at the forefront of the industry.